Occlusion Devices Market Analysis
The global Occlusion Devices Market is expected to reach USD 2,193.98 Million by 2030 at 6.2% CAGR during the forecast period 2022-2030. Occlusion refers to the closure/blockage of any organs or blood vessels. Occlusion devices, simply put, are a type of medical device which is used to treat various conditions and defects in the patient’s body, including gynecology, oncological, neurological, cardiovascular, and others. They are clinically tested as well as deemed effective to remove occlusion from different parts of the body.
Numerous factors are propelling the occlusion devices market. Such factors, as per the new Market Research Future report, include increase in geriatric population, treatment under health insurance policies, government and private organizations covering the cost of occlusion devices, increasing prevalence of neurological and heart-related disorders, increasing availability of medical reimbursements, rising use of surgical techniques that are minimally invasive, and rising target patient population.
On the contrary, strict regulations and compliances with regards to approval of occlusion devices, limitations of procedures of chronic total occlusion, high cost of devices, and lack of skilled experts are factors that may hinder the occlusion devices market growth during the forecast period.
Market Segmentation
The occlusion devices market has been segmented in terms of application, end user, and product.
By product, the devices occlusion market is segmented into occlusion removal devices, support devices, and embolization devices. Embolization devices are again segmented into liquid embolic agents as well as tubal occlusion devices. Occlusion removal is again segmented into stent retrievers, aspiration devices, balloon occlusion devices, coil retrievers, and suction. Support devices are again segmented into microcatheters as well as guidewires. Among these, occlusion removal devices will dominate the market during the forecast period.
By application, the occlusion devices market is segmented into urology, neurology, gynecology, peripheral vascular diseases, oncology, and others. Among these, neurology will have the largest share in the market during the forecast period.
By end user, the occlusion devices market is segmented into diagnostic centers, ambulatory care centers, hospitals and clinics, surgical centers, and others.
Regional Analysis
By region, the occlusion devices market report covers the latest trends and growth opportunities across North America, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, North America will have the lion’s share in the market during the forecast period. Numerous factors are propelling the growth of the occlusion devices market in the region, such as availability of advanced devices, growing demand for treatment choices of rare and chronic diseases, presence of several key players, increasing geriatric population, rising investment in healthcare, and increasing prevalence of chronic diseases.
The occlusion devices market in Europe will have a positive growth during the forecast period for the rising expenditure in healthcare, coupled with rising emphasis on the diagnosis of chronic and other related diseases. The UK and Germany are the chief contributors in this region.
The occlusion devices market in the Asia Pacific region will grow at the fastest pace during the forecast period. Numerous factors are propelling the growth of the occlusion devices market in the region such as exposure to harmful chemicals, increasing environmental pollution, addiction to smoking, the rising influence of western culture, lifestyle changes, rising focus on the early diagnosis as well as treatment of cardiovascular disease, and rising burden of various chronic diseases.
The occlusion devices market in the MEA will have a steady rise during the forecast period for the growing awareness about chronic diseases, booming medical device sector, and rise in healthcare facilities that offer treatment for chronic conditions.
Key Players
Notable players profiled in the global occlusion devices market report include Asahi Intecc, Abbott Laboratories (US), Cardinal Health, Angiodynamics, Avinger, Acrostak, Terumo Corporation, Cook Group, Penumbra, Edwards Lifesciences, Stryker Corporation, Terumo Corporation (Japan), MicroPort Scientific Corporation (China), B. Braun Melsungen AG (Germany), Translumina GmbH (Germany), Medtronic plc (Ireland), Meril Life Sciences Pvt. Ltd. (India), Biosensors International Group, Ltd. (Singapore), Vascular Concepts (India), Elixir Medical Corporation (US), Boston Scientific Corporation (US), and Kyoto Medical Planning Co. Ltd. (Japan).
More Details @ https://www.marketresearchfuture.com/reports/occlusion-devices-market-5934
Industry News
March 2021: The new Watchman FLX device from Boston Scientific has recently received CE Mark. This device will help in reducing the risk of stroke in those having non-valvular AF.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
